Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Dividend Declaration

22 Sep 2015 07:01

RNS Number : 7320Z
Charlemagne Capital Limited
22 September 2015
Β 

ο»Ώ

22 September 2015

Β 

Β 

Β 

Charlemagne Capital Limited

("Charlemagne" or the "Company")

Β 

Dividend Declaration

Β 

Further to the announcement of its interim results to 30 June 2015 earlier today, Charlemagne confirms that it has declared an interim dividend of 0.5 US cents (GB 0.3209 pence) per share.

Β 

The dividend will be paid on 6 November 2015 to shareholders on the record on 2 October 2015. Dividends will be payable in pounds sterling unless the Company's registrar holds an instruction from the shareholder to pay in US dollars. The Company's ordinary shares will go ex-dividend on 1 October 2015.

Β 

Β 

Enquiries:

Β 

Charlemagne Capital

Jane McAndry - Company Secretary

Tel. +44 1624 640200

Smithfield Consultants

John Kiely

Ged Brumby

Tel. 020 7360 4900

N+1 Singer (Nominated Adviser)

Nic Hellyer

Richard Salmond

James Maxwell

Β 

Tel. 020 7496 3000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DIVEAKNFALSSEFF
Date   Source Headline
4th Sep 20067:02 amRNSInterim Results
14th Aug 200612:00 pmRNSNotice of Interim Results
2nd Aug 20063:58 pmRNSDividend Payment Document
10th Jul 20067:00 amRNSTrading Statement
13th Jun 20067:02 amRNSMagna Asia Fund Launch
7th Jun 20067:00 amRNSTransaction in Own Shares
2nd Jun 20067:01 amRNSTransaction in Own Shares
30th May 20067:01 amRNSTransaction in Own Shares
25th May 20064:15 pmRNSDirector/PDMR Shareholding
23rd May 200612:25 pmRNSDirector/PDMR Shareholding
22nd May 20061:47 pmRNSResult of AGM
22nd May 20067:00 amRNSAGM Statement
8th May 20069:00 amRNSAuM update
5th May 20069:32 amRNSNotice of AGM
10th Apr 20067:02 amRNSQuarterly Update
30th Mar 200611:13 amRNSSch 1 Update - Charlemagne

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.